Literature DB >> 19917302

Cystatin C in macular and neuronal degenerations: implications for mechanism(s) of age-related macular degeneration.

Luminita Paraoan1, Paul Hiscott, Christine Gosden, Ian Grierson.   

Abstract

Cystatin C is a strong inhibitor of cysteine proteinases expressed by diverse cells. Variant B cystatin C, which was associated with increased risk of developing age-related macular degeneration, differs from the wild type protein by a single amino acid (A25T) in the signal sequence responsible for its targeting to the secretory pathway. The same variant conveys susceptibility to Alzheimer disease. Our investigations of the trafficking and processing of variant B cystatin C in living RPE cells highlight impaired secretion of extracellular modulators and inappropriate protein retention in RPE cells as potential molecular mechanisms underpinning macular, and possibly neuronal, degeneration. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917302     DOI: 10.1016/j.visres.2009.10.022

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  9 in total

1.  High cystatin C levels predict severe retinopathy in type 2 diabetes patients.

Authors:  Rui He; Jing Shen; Jun Zhao; Hui Zeng; Lianxi Li; Jungong Zhao; Fang Liu; Weiping Jia
Journal:  Eur J Epidemiol       Date:  2013-08-06       Impact factor: 8.082

2.  Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration.

Authors:  Patrick M Chen; Zoë J Gombart; Jeff W Chen
Journal:  Cell Biosci       Date:  2011-03-08       Impact factor: 7.133

Review 3.  The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.

Authors:  Yu-Ping Jia; Lei Sun; He-Shui Yu; Li-Peng Liang; Wei Li; Hui Ding; Xin-Bo Song; Li-Juan Zhang
Journal:  Molecules       Date:  2017-04-20       Impact factor: 4.411

Review 4.  The Diverse Roles of TIMP-3: Insights into Degenerative Diseases of the Senescent Retina and Brain.

Authors:  Jennifer M Dewing; Roxana O Carare; Andrew J Lotery; J Arjuna Ratnayaka
Journal:  Cells       Date:  2019-12-21       Impact factor: 6.600

5.  Over-expression of human cystatin C in pterygium versus healthy conjunctiva.

Authors:  Luis Fernando Barba-Gallardo; Javier Ventura-Juárez; David Kershenobich Stalnikowitz; Rafael Gutiérrez-Campos; Eugenia Torres-Bernal; Luis Fernando Torres-Bernal
Journal:  BMC Ophthalmol       Date:  2013-02-27       Impact factor: 2.209

6.  Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration.

Authors:  Xinrong Xu; Li Hang; Binglin Huang; Yuanhua Wei; Shizhong Zheng; Wei Li
Journal:  J Ophthalmol       Date:  2013-09-12       Impact factor: 1.909

Review 7.  Autophagy and heterophagy dysregulation leads to retinal pigment epithelium dysfunction and development of age-related macular degeneration.

Authors:  Kai Kaarniranta; Debasish Sinha; Janusz Blasiak; Anu Kauppinen; Zoltán Veréb; Antero Salminen; Michael E Boulton; Goran Petrovski
Journal:  Autophagy       Date:  2013-04-09       Impact factor: 16.016

8.  SPP2 Mutations Cause Autosomal Dominant Retinitis Pigmentosa.

Authors:  Yuan Liu; Xue Chen; Qihua Xu; Xiang Gao; Pancy O S Tam; Kanxing Zhao; Xiumei Zhang; Li Jia Chen; Wenshuang Jia; Qingshun Zhao; Douglas Vollrath; Chi Pui Pang; Chen Zhao
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379

9.  Cystatin C and cystatin SN as possible soluble tumor markers in malignant uveal melanoma.

Authors:  Maria A Dikovskaya; Galina S Russkikh; Konstantin V Loktev; Thomas P Johnston; Margarita M Gevorgyan; Natalya P Voronina; Valery V Chernykh; Alexander N Trunov; Tatiana A Korolenko
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.